logo
Parents Are Putting Band-Aids on Their Kids' Belly Buttons for Motion Sickness—Does It Work?

Parents Are Putting Band-Aids on Their Kids' Belly Buttons for Motion Sickness—Does It Work?

Yahoo4 days ago
Parents are swearing by this viral hack but experts say it's probably a placebo effect.
Fact checked by Sarah Scott
If you've spent any time scrolling parenting reels on TikTok and Instagram that claim to teach you the things veteran parents 'wish they knew' earlier, you've likely come across this one: sticking a criss-crossed Band-Aid (or "plaster," as it's called in the U.K.) over your kid's belly button to prevent nausea during car rides, plane travel, and even boat trips.
While there's no solid scientific evidence backing the technique, plenty of parents swear by it. Influencers including @tsagana24 and @smart.move.family have posted about the trick, with videos earning hundreds of thousands of views.
In one reel, Artem from @smart.move.family shares, 'This easy trick helped my kid with motion sickness on road trips—just stick a band-aid over their belly button. Worked like a charm on our last drive.'
We turned to the experts to find out whether the belly button Band‑Aid hack is really worth trying on your next trip out of town.
Breaking Down the Belly Button Band‑Aid Hack for Motion Sickness
The hack itself is as simple as it sounds. Before heading out on a trip, place two adhesive bandages in an 'X' shape over your kid's belly button. The direction of the placement (a vertical cross versus a diagonal one) doesn't seem to matter, nor does the size of the bandaids. In fact, some parents, like Jasmin of @rainbow.construction even opt for one large bandage instead of two smaller ones.
In one video demonstrating the hack, the momfluencer with more than 200K followers writes, 'It sounds super crazy, but it totally works for both my children...This has saved us so many times and we do it every single time we go on a longer car ride."
She even suggests it might help adults too, though admits she's not sure why it works. 'It could be placebo,' she says, 'but I also read that the band aid stimulates some acupressure points to relieve nausea.'
While acupuncture may be used to relieve nausea, these points are usually in the wrist, not the abdomen. It's also worth noting that acupuncture relies on significant and sustained pressure being applied to a specific point on the body, something that a regular adhesive bandage can't really provide.
Besides this, there's also the simple fact that there doesn't appear to be much correlation between how motion sickness actually works (a disconnect between what your eyes see and what your inner ear feels), and applying an adhesive bandage to the belly button.
Why Motion Sickness Occurs
'Motion sickness happens when our ear senses motion, but our eyes are giving the input of standing still, usually because we are reading or watching something on a screen,' explains Ali Shehata, MD, a Las Vegas-based family and emergency physician. 'This mismatch in brain signals causes nausea and dizziness.'
Kiara DeWitt, BSN, RN, CPN, a certified pediatric nurse, and the founder and CEO of Injectco, agrees, adding, 'Seriously reducing screen time during car rides eases motion sickness by over 50% for most children.'
Of course, there are plenty of other reasons kids can get sick from car rides and long travel days, even if they aren't spending their time staring at screens. Since a child's sensory system is still developing, other factors like what they've had to eat or drink that day, or even a lack of fresh air, can all lead to feelings of nausea."From a purely medical/scientific standpoint, the use of a Band-Aid over the belly button is a placebo type of treatment."
Ali Shehata, MDSo, Does the Belly Button Band‑Aid Hack Actually Work?
The short answer? Probably not, at least not according to science.
'From a purely medical/scientific standpoint, the use of a Band-Aid over the belly button is a placebo type of treatment,' says Dr. Shehata. 'It has no neurological effect and wouldn't be expected to impact motion sickness.'
DeWitt agrees. 'To be blunt, I would not say belly button plasters have a sound physiological basis for motion sickness relief,' she says. 'There's no sensory nerve cluster at the belly button that links directly to the nausea centers in the brain. Most likely, it's the placebo effect at work.'
Still, neither expert is against giving it a try, provided it's done safely.
'There's nothing wrong with trying it so long as you keep things clean and safe,' says DeWitt. 'Use fresh adhesive plasters, swap them out regularly, and avoid using them for more than a few hours at a stretch. Kids' skin can get irritated quickly.'
What Actually Helps With Motion Sickness?
Here are some time-tested strategies for nausea that may help your kiddo more than a Band-Aid on the belly.
Choose the right seat. 'Strategically positioning kids in the car, like in middle seats where there's less motion, can reduce dizziness and nausea by up to 30–40%,' says DeWitt.
Cut distractions and encourage looking outside. 'Avoid the use of screens in the car by putting tablets and phones away, as well as books,' advises Dr. Shehata. Encourage kids to look outside and keep them engaged with car games rather than screens.
Try natural aids. 'Ginger chews or drops can help, especially if taken 30 minutes before a trip,' says DeWitt. For older kids, peppermint-flavored gum or candy can also help ease a queasy stomach.
Keep them hydrated. 'Even a 2% fluid loss can mess with your equilibrium,' DeWitt warns. Pack plenty of water and easy-to-digest snacks for your trip.
If your child continues to struggle with motion sickness, especially to the point of vomiting, turning pale, or avoiding car rides altogether, it might be time to check in with your health care provider.
'For the rare few that continue to have symptoms, more testing or medication might be needed,' says Dr. Shehata. 'Don't hesitate to check in with your provider.'
Read the original article on Parents
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ketamine's Antidepressant Action May Depend on Opioid System
Ketamine's Antidepressant Action May Depend on Opioid System

Medscape

time6 minutes ago

  • Medscape

Ketamine's Antidepressant Action May Depend on Opioid System

Activation of the body's opioid system may be required for ketamine's antidepressant effects, new research hinted. In a small study of adults with major depressive disorder, taking the opioid blocker naltrexone before a low-dose ketamine infusion both blunted the surge in glutamate — a key brain chemical linked to mood — and reduced ketamine's rapid antidepressant benefit the next day. 'These results suggest that opioid receptors help mediate ketamine's effects and that blocking opioid receptors may lessen ketamine's acute mood-lifting action,' lead researcher Luke Jelen, MBBS, clinical lecturer in psychiatry, King's College London, London, England, told Medscape Medical News . 'However, this was a small, mechanistic study, not a treatment trial, so there is no immediate indication to change clinical practice or avoid naltrexone. Larger, dedicated clinical studies are required before recommending any alteration to current protocols,' Jelen cautioned. The study was published online on July 24 in Nature Medicine . New Mechanistic Insights Ketamine's rapid-acting antidepressant effects are thought to work by transiently elevating glutamate in the anterior cingulate cortex and other frontal regions, setting off a cascade of plasticity-related pathways. Prior animal and small human studies have suggested that activating mu-opioid receptors might be necessary for ketamine's mood benefits. To investigate, Jelen and colleagues enrolled 26 adults with moderate-to-severe depression in a randomized double-blind crossover trial separated by 3 weeks. Participants received either oral placebo or 50 mg naltrexone 1 hour before receiving intravenous ketamine (0.5 mg/kg). During the first 30 minutes of each infusion, they measured brain glutamatergic activity in the anterior cingulate cortex using functional magnetic resonance spectroscopy. Depressive symptoms were measured before and 24 hours after infusion, when ketamine's antidepressant effects peak, using the Montgomery-Åsberg Depression Rating Scale (MADRS). Compared with placebo, pretreatment with a single 50-mg dose of oral naltrexone reduced the brain's glutamatergic response and dampened the average improvement on MADRS measured 24 hours later, the researchers observed. Specifically, the glutamate signal climbed significantly during ketamine when participants had taken placebo, but the rise was significantly smaller when they had taken naltrexone ( P = .029; Cohen's d = 0.34). 'We also identified a sex-related effect: The attenuating effect of naltrexone on glutamate activity appeared more pronounced in males with depression than in females with depression,' Jelen said. Alongside the attenuation of ketamine-induced glutamatergic activity, naltrexone pretreatment also led to less marked reductions in clinician-rated MADRS scores 24 hours after infusion — equating to a 28% attenuation in the main effect of ketamine ( P = .023), the researchers reported. Reductions in self-reported depressive measures were numerically lower in the presence of naltrexone than in the presence of placebo, but the differences were not statistically significant. 'The possibility of an opioid mechanism underlying the antidepressant mechanisms of ketamine has been a recent subject of considerable debate. Our study provides evidence that opioid system activation may contribute to the acute antidepressant effects of ketamine,' the authors wrote. Looking ahead, Jelen told Medscape Medical News , a larger, well-powered study should include a true placebo-infusion arm to disentangle naltrexone's effects on both ketamine and placebo responses. He also noted that adding PET imaging would directly quantify opioid-receptor engagement, and prespecified analyses by sex are essential, given the stronger glutamate-dampening effect observed in men. 'Understanding more about how ketamine works can lead to treatment being personalized for different people, which is vital for creating safe and effective treatments,' Jelen said.

Postcode lottery for Mounjaro, the 'King Kong' of weight loss jabs, with only eight NHS care boards providing treatment
Postcode lottery for Mounjaro, the 'King Kong' of weight loss jabs, with only eight NHS care boards providing treatment

Yahoo

time37 minutes ago

  • Yahoo

Postcode lottery for Mounjaro, the 'King Kong' of weight loss jabs, with only eight NHS care boards providing treatment

Thousands of severely obese patients are facing severely delayed treatment with what's been called the 'King Kong' of weight loss jabs - because the NHS rollout has been mismanaged and underfunded, according to Sky News research. Mounjaro was supposed to be available through GP surgeries and other community services from 23 June under an agreement between NHS England and the National Institute for Health and Care Excellence (NICE), the body that provides guidance on the use of new drugs. But Freedom of Information requests by Sky News reveal a postcode lottery, with only eight of 42 NHS Integrated Care Boards (ICBs) in England telling us they were providing treatment to patients, and many of the rest unable to guarantee when it would be available. The research also shows that at least 19 had a cap on how many eligible patients they would treat in the first year. Dr Jonathan Hazlehurst, an specialist at University Hospitals Birmingham, said many patients were desperate for treatment - and Mounjaro may be a hopeful aid for those eligible. "Giving people open promises and setting them up for disappointment and failure is clearly grossly unfair," he said. "That's what the current system is doing." NICE said in December that the NHS should offer Mounjaro to patients with a BMI over 40 and at least four clinical conditions related to their weight, such as heart disease or type 2 diabetes. It calculated from NHS England data that there were 97,500 patients who should be treated in the first year. But Dr Hazelhurst says NHS England has only provided funding for just over 22,000 patients. Read more: "It shows that there's a lack of political will to fund this adequately," he said. "NHS England says that obesity costs the NHS £11.4bn per annum as a pure NHS cost. "Yet we can't even afford to properly fund the rollout of a life-changing drug in year one. That just doesn't make any sense." Gary - who doesn't want his surname used - weighs 25 stone (158kg) and becomes severely out of breath after climbing only a few stairs. He is eligible for treatment with Mounjaro under the agreed NHS guidelines. But his surgery said "no" and told him it would be at least the autumn before the drug would be available in the Hampshire area. "They said to us that September would be the earliest they going to look at it and then the criteria might change, so there's no knowing if I'm going to get it," he said. "I was so excited when I read about this drug. If I had the drug and lost some weight, it could help me move around, it could help me go fishing again, all kinds of things. "It's not for vanity. It would be a life changer." There are 3.4 million people in England who would qualify for treatment under the NICE eligibility criteria. But NHS England has said it will take 12 years to assess and prescribe to those who need it. Dr Hazlehurst said there would never be such a slow rollout with a new cancer treatment - and yet, obesity also kills. "There's a huge amount of stigma that drives things to do with obesity care all across the system," he said. "The 'eat less, move more' nonsense doesn't help. "That is a really unhelpful, harmful and stigmatising approach, particularly in an age of effective treatment." Read more from Thomas Moore: A spokesperson for NHS England said it had "fully supported the rollout" of Mounjaro. They said: "We issued guidance and provided funding in March to all Integrated Care Boards to support treatment costs, enable scaling of services and provide wrap-around care, including digital support services."

Ryanair sets monthly passenger record despite air traffic control strikes
Ryanair sets monthly passenger record despite air traffic control strikes

Yahoo

time37 minutes ago

  • Yahoo

Ryanair sets monthly passenger record despite air traffic control strikes

Airline Ryanair said it carried a record high number of passenger last month despite French air traffic control (ATC) strikes. The Dublin-based carrier announced 20.7 million passengers travelled on its flights in July. That is up 3% from 20.2 million during the same month last year. Its load factor – which represents the average proportion of seat filled on its aircraft – was stable at 96%. Ryanair said it operated more than 113,000 flights in July and cancelled 680, mainly because of French controller strikes. French ATC staff took industrial action on July 3 and 4 in a dispute over working conditions. As well as disrupting flights to and from French airports, the walkouts affected flights scheduled to travel over French airspace. This meant many services to or from UK airports were delayed or cancelled. EasyJet chief executive Kenton Jarvis previously described the French strikes as 'very, very disruptive' as they forced the airline to cancel 660 flights and cost it £15 million. Around 70% of easyJet's flights either fly to or from a French airport, or over the country's airspace. European air traffic management body Eurocontrol estimated the strikes affected more than one million passengers. Meanwhile, a radar fault suffered by UK ATC provider Nats led to more than 100 UK flights being cancelled on July 30.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store